1. Home
  2. HI vs MESO Comparison

HI vs MESO Comparison

Compare HI & MESO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HI
  • MESO
  • Stock Information
  • Founded
  • HI 2007
  • MESO 2004
  • Country
  • HI United States
  • MESO Australia
  • Employees
  • HI N/A
  • MESO N/A
  • Industry
  • HI Miscellaneous manufacturing industries
  • MESO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • HI Consumer Discretionary
  • MESO Health Care
  • Exchange
  • HI Nasdaq
  • MESO Nasdaq
  • Market Cap
  • HI 2.1B
  • MESO 1.7B
  • IPO Year
  • HI N/A
  • MESO N/A
  • Fundamental
  • Price
  • HI $24.75
  • MESO $11.82
  • Analyst Decision
  • HI Buy
  • MESO Buy
  • Analyst Count
  • HI 2
  • MESO 4
  • Target Price
  • HI $36.50
  • MESO $18.00
  • AVG Volume (30 Days)
  • HI 450.6K
  • MESO 296.3K
  • Earning Date
  • HI 04-29-2025
  • MESO 02-26-2025
  • Dividend Yield
  • HI 3.63%
  • MESO N/A
  • EPS Growth
  • HI N/A
  • MESO N/A
  • EPS
  • HI N/A
  • MESO N/A
  • Revenue
  • HI $3,116,400,000.00
  • MESO $5,670,000.00
  • Revenue This Year
  • HI N/A
  • MESO $228.57
  • Revenue Next Year
  • HI N/A
  • MESO $356.77
  • P/E Ratio
  • HI N/A
  • MESO N/A
  • Revenue Growth
  • HI 5.87
  • MESO N/A
  • 52 Week Low
  • HI $23.20
  • MESO $4.60
  • 52 Week High
  • HI $50.06
  • MESO $22.00
  • Technical
  • Relative Strength Index (RSI)
  • HI 37.34
  • MESO 31.06
  • Support Level
  • HI $23.20
  • MESO $13.60
  • Resistance Level
  • HI $26.70
  • MESO $14.45
  • Average True Range (ATR)
  • HI 0.85
  • MESO 0.48
  • MACD
  • HI 0.07
  • MESO -0.06
  • Stochastic Oscillator
  • HI 44.29
  • MESO 1.50

About HI Hillenbrand Inc

Hillenbrand Inc is a U.S.-based company that operates through three segments. The Advanced Process Solutions segment designs, develops, manufactures, and services engineered industrial equipment. The Molding Technology Solutions segment offers engineered and customized systems in plastic technology and processing. Batesville designs provides, and markets funeral services and solutions.

About MESO Mesoblast Limited

Mesoblast Ltd is a biotechnology company. It uses its proprietary technology platform to develop and commercialize allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care and where inflammation plays a central role. The company's product candidates include; Ryoncil (remestemcel-L) for the treatment of steroid refractory acute graft versus host disease as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of cell technology platform for commercialization.

Share on Social Networks: